Oxomemazine

DB13820InvestigationalSmall molecule

Oxomemazine is a phenothiazine derivative antihistamine indicated in the treatment of allergies. A medication used to treat allergies.

Chemical structure of Oxomemazine
Mechanism
Curator reviewed · 1 reference
Formula / weight
C18H22N2O2S · 330.45 g/mol (avg)

Resolves to

Compound
UNII305MB38V1CCAS3689-50-7ChEMBLCHEMBL2104734ChEBI135408PubChem19396
Clinical / RWD
ATCR06AD08
Structure
InChIKeyQTQPVLDZQVPLGV-UHFFFAOYSA-NSMILESCC(CN(C)C)CN1C2=CC=CC=C2S(=O)(=O)C2=CC=CC=C12
Targets
P35367HRH1P11229CHRM1

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
9Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
10Marketed productsAcross 1 country and 7 labellers
Sign in
1ATC codeIncluding every combination product, plus 4 drug categories
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxomemazine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In